Table 1.

Most frequent BCP-ALL subtypes in AYA

EntityDescriptionPrevalence (AYA)Prognosis
BCR::ABL1 t(9;22)(q34;q11) 5%-20% Int 
Ph-like 1) Jak/STAT activation (CRLF2-r) 25%-30% Unf 
 2) ABL-class fusions   
 3) Others (NTRK3-, FGFR1-, FLT3-, TYK2-r)   
Hyperdiploid 51-67 chr. 11% Fav 
Hypodiploid Low: 32-39 chr 10%-15% Unf 
 Near haploid: 24-31 chr <3% Unf 
KMT2A-r t(v;11q23.3) 8% Unf 
DUX4-r Associated with ERG deletion 8% Fav 
PAX5alt Diverse PAX5 alterations 8% Int 
PAX5-P80R Biallelic alterations 5% Fav 
iAMP21 Intrachromosomic amplification <5% Unf 
ZNF384-r partner genes: EP300, TCF3, CREBBP <5% Int 
MEF2D-r partner genes: BCL9, HNRNPUL1 <5% Unf 
TCF3::PBX1 t(1;19)(q23;p13.3) <5% Int 
ETV6::RUNX1 t(12;21) (p12;q22) <5% Fav 
MYC-r/BCL2-r  <5% Unf 
CDX2/UBTF::ATXN7L3 CDX2 cis-deregulation <5% Unf 
TCF3::HLF t(17;19)(q22;p13) <1% Unf 
IGH::IL3 t(5;14)(q31.1;q32.3) <1% Unf 
EntityDescriptionPrevalence (AYA)Prognosis
BCR::ABL1 t(9;22)(q34;q11) 5%-20% Int 
Ph-like 1) Jak/STAT activation (CRLF2-r) 25%-30% Unf 
 2) ABL-class fusions   
 3) Others (NTRK3-, FGFR1-, FLT3-, TYK2-r)   
Hyperdiploid 51-67 chr. 11% Fav 
Hypodiploid Low: 32-39 chr 10%-15% Unf 
 Near haploid: 24-31 chr <3% Unf 
KMT2A-r t(v;11q23.3) 8% Unf 
DUX4-r Associated with ERG deletion 8% Fav 
PAX5alt Diverse PAX5 alterations 8% Int 
PAX5-P80R Biallelic alterations 5% Fav 
iAMP21 Intrachromosomic amplification <5% Unf 
ZNF384-r partner genes: EP300, TCF3, CREBBP <5% Int 
MEF2D-r partner genes: BCL9, HNRNPUL1 <5% Unf 
TCF3::PBX1 t(1;19)(q23;p13.3) <5% Int 
ETV6::RUNX1 t(12;21) (p12;q22) <5% Fav 
MYC-r/BCL2-r  <5% Unf 
CDX2/UBTF::ATXN7L3 CDX2 cis-deregulation <5% Unf 
TCF3::HLF t(17;19)(q22;p13) <1% Unf 
IGH::IL3 t(5;14)(q31.1;q32.3) <1% Unf 

Fav, favorable; Int, intermediate; Unf, unfavorable.

Close Modal

or Create an Account

Close Modal
Close Modal